nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

24.04.2020 | Letter to the Editor

Activity of temocillin and comparators against urinary Escherichia coli and Klebsiella pneumoniae from Iran

verfasst von: Mohammad Rahbar, Sébastien Van de Velde, Parisa Eslami, Masoud Mardani

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the ground susceptibility of urinary Escherichia coli and Klebsiella pneumoniae to temocillin, the susceptibility of temocillin and comparators against 500 clinical isolates (231 E. coli and 269 K. pneumoniae) was tested. Temocillin was either found as the most active antibiotic (susceptibility rate of 92%) or the fourth most active antibiotic (65%), as per its urinary and systemic breakpoint, respectively. No difference of activity was observed in isolates expressing ESBL/AmpC enzymes. Considering the percentage of isolates expressing beta-lactamases and the need to spare broad-spectrum antibiotics, temocillin seems promising for treating urinary tract infections.

Nur mit Berechtigung zugänglich

Kuch A, Zieniuk B, Zabicka D, Van de Velde S, Literacka E, Skoczynska A, Hryniewicz W (2020) Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-020-03844-5

Woodford N, Pike R, Meunier D, Loy R, Hill R, Hopkins KL (2014) In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. J Antimicrob Chemother 69(2):564–567. https://doi.org/10.1093/jac/dkt383CrossRefPubMed

Tsakris A, Koumaki V, Politi L, Balakrishnan I (2020) Activity of temocillin against KPC-producing Enterobacteriaceae clinical isolates. Int J Antimicrob Agents 55(1):105843. https://doi.org/10.1016/j.ijantimicag.2019.10.024CrossRefPubMed

Adams-Haduch JM, Potoski BA, Sidjabat HE, Paterson DL, Doi Y (2009) Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 53(6):2700–2701. https://doi.org/10.1128/aac.00290-09CrossRefPubMedPubMedCentral

Aminzadeh Z, Sadat Kashi M, Sha'bani M (2008) Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in south of Tehran, Iran. Iran J Kidney Dis 2(4):197–200PubMed

Moayednia R, Shokri D, Mobasherizadeh S, Baradaran A, Fatemi SM, Merrikhi A (2014) Frequency assessment of beta-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Res Med Sci 19(Suppl 1):S41–S45PubMedPubMedCentral

Shahbazi S, Asadi Karam MR, Habibi M, Talebi A, Bouzari S (2018) Distribution of extended-spectrum beta-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist 14:118–125. https://doi.org/10.1016/j.jgar.2018.03.006CrossRefPubMed

Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR (2018) Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party. J Antimicrob Chemother 73(suppl_3):iii2–iii78. https://doi.org/10.1093/jac/dky027CrossRefPubMed

Belgian Antibiotic Policy Coordination Committee (2017) Recommandations de traitements anti-infectieux en milieu hospitalier. Accessed 11 Mar 2020, https://organesdeconcertation.sante.belgique.be/sites/default/files/documents/bapcoc_guidelineshospi_2017_sbimc-bvikm_fr_v1.pdf

10.

Caron F, Galperine T, Flateau C, Azria R, Bonacorsi S, Bruyere F, Cariou G, Clouqueur E, Cohen R, Doco-Lecompte T, Elefant E, Faure K, Gauzit R, Gavazzi G, Lemaitre L, Raymond J, Senneville E, Sotto A, Subtil D, Trivalle C, Merens A, Etienne M (2018) Practice guidelines for the management of adult community-acquired urinary tract infections. Med Mal Infect 48(5):327–358. https://doi.org/10.1016/j.medmal.2018.03.005CrossRefPubMed

Titel: Activity of temocillin and comparators against urinary Escherichia coli and Klebsiella pneumoniae from Iran
verfasst von: Mohammad Rahbar
Sébastien Van de Velde
Parisa Eslami
Masoud Mardani
Publikationsdatum: 24.04.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2020
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-03898-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Activity of temocillin and comparators against urinary Escherichia coli and Klebsiella pneumoniae from Iran

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2020

Hepatosplenic bartonellosis in immunocompetent adults: a case series and literature review

Comparison of Legionella K-set® and BinaxNOW® Legionella for diagnosing Legionnaires’ disease on concentrated urine samples

Pharyngeal carriage rates of Neisseria meningitidis in health care professionals at a tertiary university pediatric hospital

The genetic sequence, origin, and diagnosis of SARS-CoV-2

Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli

Infection and colonization by Corynebacterium pseudodiphtheriticum: a 9-year observational study in a university central hospital

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin